Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2026 17:20 ET | Source: Robbins Geller Rudman & Dowd LLP

INVESTOR NOTICE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

The case alleges ADMA Biologics and certain of its executives made false and/or misleading statements to investors.